Microdose Psychedelic Insights is a cutting-edge media firm that aims to bring the psychedelics sector to the forefront of contemporary medicine by developing appealing content, disseminating financial analyses, and holding interesting industry events. On January 27, 2022 Microdose will host the Psychedelic Capital conference. Attendees will have access to the top firms, most recent IPOs, newest opportunities, and most in-depth market knowledge in the rapidly rising psychedelic medicine sector at the virtual event.
The Psychedelic Capital Conference has firmly established itself as the top event for the psychedelic business, with a variety of outstanding keynote addresses and fireside conversations alongside some of the industry’s most prominent speakers and thought leaders. In addition to serving as a venue for thought leadership, the conference allows guests to network with key figures in research, policy, and industry.
For more information about the Psychedelic Capital Jan 27 conference, including registration and complimentary tickets, please visit https://ibn.fm/U3lDD.